GLP-1 drugs arent new, having been used to treat Type 2 diabetes since 2005
or severe, persistent heartburn or reflux symptoms not responding to over-the-counter antacids
FDA-approved weight management medications beyond GLP-1 agonists include: Phentermine-topiramate (Qsymia): Combination sympathomimetic and anticonvulsant showing 8-10% weight loss in clinical trials
Recognizing that every body is different, Nurx offers treatment adjustment when needed and prides itself on individualized care
These risks in humans are unknown, but retatrutide is contraindicated for individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
As part of an ABC investigation, a chemical testing laboratory in Melbourne analysed the weight loss peptide retatrutide, which was acquired from an unregulated internet site